University of Cambridge study shows how LLM GPT-4 can generate novel combinations of drugs not typically used to treat cancer to be repurposed as potential breast cancer treatment in the future.

A breakthrough in AI breast cancer detection technology has been approved by the FDA. The tech company, "Clairity," is responsible for the first FDA-approved AI platform that helps predict a woman ...

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early detection and prevention.

In a large Norwegian study, a commercial AI tool analyzed routine mammograms and identified women at elevated risk of developing breast cancer up to 4–6 years before diagnosis. These AI ...

Press Release Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a ...

Key Takeaways AI can help better identify women eligible for targeted breast cancer treatment With AI, pathologists can accurately identify these women nearly 90% of the time The AI helps ...

While AI holds promise for improving breast cancer screening, we should proceed cautiously.

Global breast cancer statistics, challenges, and AI integration in India for early detection and improved outcomes.

They found one more cancer for every 1,000 women than humans alone did, according to researchers. It was the largest real-world exploration to date into the use of AI to help detect breast cancer.

The Department for Health and Social Care (DHSC) has announced an £11m pilot project, aiming to use artificial intelligence (AI) to help radiologists find breast cancer quicker.

In this Woman's Doctor segment, medical technology has come a long way and AI is taking over the conversation.

Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.